Bacteriophage ZCKP1: A Potential Treatment for Isolated From Diabetic Foot Patients.

The recorded growth in infection by multidrug resistant bacteria necessitates prompt efforts toward developing alternatives to antibiotics, such as bacteriophage therapy. Immuno-compromised patients with diabetes mellitus are particularly prone to foot infections by multidrug resistant , which may be compounded by chronic osteomyelitis. Bacteriophage ZCKP1, isolated from freshwater in Giza, Egypt, was tested to evaluate its lytic activity against a multidrug resistant KP/01, isolated from foot wound of a diabetic patient in Egypt.